Combination chemotherapy with diaziquone and amsacrine in relapsed and refractory acute nonlymphocytic leukemia: a Cancer and Leukemia Group B Study
Schiffer, C.A.; Davis, R.B.; Mayer, R.J.; Peterson, B.A.; Lee, E.J.
Cancer Treatment Reports 71(9): 879-880
1987
ISSN/ISBN: 0361-5960 PMID: 3621225 Document Number: 293677
Document emailed within 1 workday
Related Documents
Abrams, R.A.; Hanson, G.; Hansen, R.M.; Anderson, T. 1986: Phase Ii study of combination chemotherapy with etoposide and amsacrine in relapsed adult leukemia Cancer Treatment Reports 70(4): 535Berman, E.; Arlin, Z.A.; Gaynor, J.; Miller, W.; Gee, T.; Kempin, S.J.; Mertelsmann, R.; Andreeff, M.; Reich, L.; Nahmias, N. 1989: Comparative trial of cytarabine and thioguanine in combination with amsacrine or daunorubicin in patients with untreated acute nonlymphocytic leukemia: results of the L-16M protocol Leukemia 3(2): 115-121
Kaplan, H.G.; Appelbaum, F.R.; Cheever, M.A.; Greenberg, P.D.; Wood, T.; Fefer, A. 1982: Treatment of refractory acute nonlymphocytic leukemia with a combination of pyrazofurin and cytarabine Cancer Treatment Reports 66(6): 1397-1398
Kobayashi, T.; Ogawa, M.; Kuraishi, Y.; Nagata, T.; Aiba, K.; Nakamura, T.; Usui, N.; Yamazaki, H.; Ichiba, K.; Isogai, Y. 1988: DCTP(II) combination chemotherapy of adult acute nonlymphocytic leukemia Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 51(5): 855-863
Bassan, R.; Lerede, T.; Buelli, M.; Borleri, G.; Bellavita, P.; Rambaldi, A.; Barbui, T. 1998: A new combination of carboplatin, high-dose cytarabine and cross-over mitoxantrone or idarubicin for refractory and relapsed acute myeloid leukemia Haematologica 83(5): 422-427
Martino, R.; Guardia, R.; Altés, A.; Sureda, A.; Brunet, S.; Sierra, J. 1999: Time sequential chemotherapy for primary refractory or relapsed adult acute myeloid leukemia: results of the phase II Gemia protocol Haematologica 84(3): 226-230
Baehner, R.L.; Bernstein, I.D.; Sather, H.; Higgins, G.; McCreadie, S.; Chard, R.L.; Hammond, D. 1984: Contrasting benefits of two maintenance programs following identical induction in children with acute nonlymphocytic leukemia: a report from the Childrens Cancer Study Group Cancer Treatment Reports 68(10): 1269-1272
Sanz, G.F.; Sanz, M.A.; Rafecas, F.J.; Martínez, J.A.; Martín-Aragonés, G.; Marty, M.L. 1986: Teniposide and cytarabine combination chemotherapy in the treatment of relapsed adolescent and adult acute lymphoblastic leukemia Cancer Treatment Reports 70(11): 1321-1323
Griffin, J.D.; Maguire, M.E.; Mayer, R.J. 1985: Amsacrine in refractory acute leukemia Cancer Treatment Reports 69(7-8): 787-789
Wan, Q.; Xi, A.; Zhang, C.; Liu, X. 2011: Clinical study of kangai injection plus FLAG regimen for refractory/relapsed acute leukemia Zhongguo Zhong Yao Za Zhi 36(22): 3207-3209
Miyawaki, S.; Mizoguchi, H.; Tomonaga, M.; Kanamaru, A.; Tsukagoshi, S.; Nakamura, T.; Ohashi, Y.; Yoshida, S.; Ohno, R. 1998: A phase Ii study with high-dose cytarabine (NS-075) in adult patients with relapsed and refractory acute leukemia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(14): 2229-2242
Amrein, P.C.; Coleman, M.; Richards, F.; Bhardwaj, S.; Kennedy, B.J.; Haurani, F.I.; Frelick, R.W.; Pastmantier, M.W.; Herschkopf, R. 1984: Treatment of metastatic ovarian carcinoma with amsacrine: a cancer and leukemia group B phase Ii study Cancer Treatment Reports 68(11): 1397-1398
Asou, N.; Adachi, K.; Tamura, J.; Kanamaru, A.; Kageyama, S.; Hiraoka, A.; Omoto, E.; Akiyama, H.; Ohno, R. 2000: Treatment of acute promyelocytic leukemia with all-trans retinoic acid and chemotherapy--multicenter trial of the Japan Adult Leukemia Study Group (JALSG) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(8): 1168-1173
Okamoto, T.; Kanamaru, A.; Shimazaki, C.; Motoji, T.; Takemoto, Y.; Takahashi, M.; Fukushima, T.; Takeshita, A.; Kusumoto, G.S.; Kishimoto, Y.; Yorimitsu, S.; Tsukuda, K.; Uike, N.; Arima, N.; Ohno, R. 2000: Combination chemotherapy with risk factor-adjusted dose attenuation for high-risk myelodysplastic syndrome and resulting leukemia in the multicenter study of the Japan Adult Leukemia Study Group (JALSG): results of an interim analysis International Journal of Hematology 72(2): 200-205
Vinciguerra, V.; Anderson, K.; McIntyre, O.R. 1985: Diaziquone for resistant multiple myeloma. Cancer and Leukemia Group B Cancer Treatment Reports 69(3): 331-332
Prentice, H.G.; Robbins, G.; Ma, D.D.; Ho, A.D. 1984: Mitoxantrone in relapsed and refractory acute leukemia Seminars in Oncology 11(3 Suppl 1: 32-35
Yoshida, M.; Tsunoda, S.; Akutsu, M.; Furukawa, Y.; Takeda, K.; Akashi, M.; Komatsu, N.; Muroi, K.; Ikeda, K.; Ohsaka, A. 1987: The clinical effect of low-dose Ara-C in patients with refractory acute nonlymphocytic leukemia and myelodysplastic syndrome Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(4): 1057-1062
Weiss, M.A. 1997: Treatment of adult patients with relapsed or refractory acute lymphoblastic leukemia (ALL) Leukemia 11(Suppl): S28-S30
Wakita, A.; Murase, T.; Uchida, T.; Fujiwara, Y.; Tanaka, M.; Ohkita, T. 1992: Mitoxantrone and conventional-dose cytosine arabinoside for relapsed and refractory acute leukemia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(5): 653-657
Shimokawa, T.; Kojima, Y. 2008: Reinduction therapy with gemtuzumab ozogamicin for relapsed or refractory CD33-positive acute myelogeneous leukemia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(8): 1427-1430